ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

FUM Futura Medical Plc

35.60
-0.60 (-1.66%)
Last Updated: 08:00:14
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Futura Medical Plc LSE:FUM London Ordinary Share GB0033278473 ORD 0.2P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  -0.60 -1.66% 35.60 35.65 36.95 35.60 35.60 35.60 12,476 08:00:14
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Pharmaceutical Preparations 0 -5.85M -0.0194 -18.66 108.86M
Futura Medical Plc is listed in the Pharmaceutical Preparations sector of the London Stock Exchange with ticker FUM. The last closing price for Futura Medical was 36.20p. Over the last year, Futura Medical shares have traded in a share price range of 24.10p to 67.00p.

Futura Medical currently has 300,712,293 shares in issue. The market capitalisation of Futura Medical is £108.86 million. Futura Medical has a price to earnings ratio (PE ratio) of -18.66.

Futura Medical Share Discussion Threads

Showing 18701 to 18716 of 21425 messages
Chat Pages: Latest  749  748  747  746  745  744  743  742  741  740  739  738  Older
DateSubjectAuthorDiscuss
25/4/2023
11:57
Yesterday there was a request from dozey not to report single Eroxon orders as the bigger picture is more important. As I was the only one doing it I assumed it was directed towards me. So I am sorry if it was irritating other users but what I was really trying to achieve was to show that whenever I looked at the boots.com website at various times in the day there were always new/very recent purchase and clearly Eroxon is selling fast. It wasn't really about the individual orders at all.

Anyway, not to worry, but I can confirm sales are still brisk today peeps.

Looking forward to hearing Eroxon is also being stocked in the other major pharmacy chains.

Looking forward to FDA approval.

broomrigg
25/4/2023
11:56
That's tough luck, glovey, having to rely on tadalafil. I bet you wished Eroxon worked for you like it does for so many others, according to all the 5 star reviews. I suppose at least Cialis is a bit safer than viagra though. Wouldn't want to be you!
petroc
25/4/2023
11:09
"you said 'it doesn't work either' so presumably you've tries Eroxon, and you still can't get it up. Never mind, eh?"

That's right Pet, and I don't mind because Tadalafil does.

How about you? You're not still too shy to say are you Pet? It's ok, don't be timorous, you are amongst friends here :-)

glavey
25/4/2023
10:59
No understanding about anything, Mike, particularly investing, having lost all his money on CSD500 - yes, the very stuff he depicts on his Blue Diamond avatar! Quite fitting that he switched his avatar from Gordon Gecko! Hahahaha! What a massive loser, in all senses of the word!
petroc
25/4/2023
10:54
Thanks PDT, nice to get that info
broomrigg
25/4/2023
10:33
For research purposes I decided to buy some. Large Boots in centre of Eastbourne Sold Out. Another local Boots Sold Out. Went to order online and was hoping for next day delivery but not an option. Seems to be selling well :)
pdt
25/4/2023
10:06
‘Rub on pain products – what you need to know’

‘For many other rubbed-on products for pain relief (herbal remedies, salicylates, menthols, and some NSAID preparations) we have no evidence or so little evidence that we cannot trust it. It may work, but if you buy it, you have no idea whether you are buying something really good or just wasting your money. Experience suggests the latter, but if you have a remedy you swear by, stick with it. I know a chap who swears by rubbing WD40 on a sore back, but I wouldn’t recommend it’

lbo
25/4/2023
09:48
Does Voltaren work better then Flexiseq? Has a direct blind efficacy study been done?



Does TPR100 work better then Flexiseq?

We do know TPR100 gel (Dermasys plus Diclofenac) didn’t work better then Voltaren!



˜TPR100 gave similar results to the gold standard, Voltarol 2% gel’

lbo
25/4/2023
09:33
https://www.smsna.org/patients/blog/the-role-of-the-mind-in-erections-and-erectile-dysfunctionThe Role of the Mind in Erections and Erectile Dysfunction
lbo
25/4/2023
09:33
Cant I just take a tablet?

˜If you can get an erection in one situation and not the other, you do not need Viagra’

So via the non standard inclusion criteria in FM57. They only included men who already reported getting an erection with mechanical stimulation. So the men in FM57 could get an erection in one situation!

So if the organic issue that Viagra counteracts is ruled out by the FM57 inclusion criteria then the men didn’t physiologically or biologically need to wait for viagra or any drug to work or to have a pharmacologic effect!

They just need more arousal, or just a placebo!

Or they need to be told the truth rather then be scammed into overpaying for a placebo arousal gel. Or they need to be offered CBT/psychotherapy to find out what is underlying the psychological issue.

Also any placebo will work that the man believes will work!

Including a cooling lubricant or arousal

lbo
25/4/2023
08:27
Eroxon showing up on boots homepage!.
rv2
25/4/2023
02:40
Tried Voltarol, that doesn't work either.
glavey
24/4/2023
22:26
Voltarol Emugel vehicle gel is made of the same ‘evaporative cooling’ ingredients as in Eroxon

carbomer,
isopropyl alcohol,
propylene glycol,
water



Even ‘TPR100 (another Futura product but delivering Diclofenac) gave similar results to the gold standard, Voltarol 2% gel’



The cooling effect of a topically applied product can be evaluated using a validated handheld thermal imaging system. When the gel matrix is destroyed after application to the skin, the bound water and alcohol evaporates and a measurable cooling-effect results. Consumer satisfaction with a topical product is based on subjective criteria such as how the product feels and how it is perceived on the skin. Therefore, appropriate questionnaires are of major importance for cosmetic products to assess the subjective perception not only of soothing and cooling effects but also of moisturizing properties and fragrance.



Skin hydration and cooling effect produced by the Voltaren® vehicle gel

lbo
24/4/2023
22:18
Yeah long way to go to build it into a long term sustainable brand with regular repeat customers! Especially when theres still no enforceable patent so anyone can copy it based on the Voltaren vehicle ingredients being the same! Or as Futura openly admitted in the results. They will need to ˜work hard’ to try turn it ˜into a long term, profitable and trusted brand."



2013

Chemist shops sold out of new treatment three times since product came out in June

flying off pharmacy shelves at the rate of 15,000 tubes a week



The secured loan of US$15 million, which matures on June 25, 2018, will bear interest at 12% per annum plus other additional consideration. The interest rate will decrease to 10% if Pro Bono Bio meets certain equity-fundraising targets. The loan is secured by a charge over the assets of Pro Bono Bio and its affiliates which includes but is not limited to Flexiseq, an innovative topical pain product that has sales of more than 3 million units since its U.K. launch last year.




In 2017, PBB was on the verge of bankruptcy, because it could not pay interest on the loan of 15 million pounds, taken in 2015 by the Canadian Knight Therapeutics.

lbo
24/4/2023
20:53
Went into a branch of Boots with 10 packs on open display . Not in large plastic boxes as seen elsewhere . Small security tag stuck on back which I am sure could be removed with a blade . That will help our sales .

Pleased to see someone else suggested not to list individual sales .

haroldthegreat
24/4/2023
19:35
But is it ‘fair enough’ to claim a medical device is ‘clinically proven’ when the studies were not
adequately placebo controlle? Doesn’t seem so according to the relevant ASA rulings!


Medical device claims that breach CAP Code (Edition 12) rules 3.1 (Misleading advertising), 3.7 (Substantiation) and 12.1 Medicines, medical devices

‘Because the trial was not placebo-controlled’

˜had not provided adequate evidence to support the claim ˜clinically proven’ ˜concluded that the claim had not been substantiated and was misleading’



Assessment
Upheld

The ASA noted that the product appeared to meet the requirements of the Medical Device Directive (MDD) but understood that the MDD did not harmonise EU law relating the advertising of medical devices, which was subject to Directive 2005/29/EC on unfair business to consumer commercial practices (including advertising) generally (Unfair commercial practices directive - UCPD). That meant that advertisers must still meet the requirements of the CAP Code, which reflected the provisions of UCPD. Under the CAP and BCAP Codes, medical claims could be made for CE-marked medical devices provided they complied with other requirements of the Codes, including those relating to substantiation.
CE certification in itself does not constitute evidence for medical efficacy claims, and advertisers need to ensure that they hold evidence for such claims.
There was no statistically significant difference between the outcomes for the treatment group (patients using the Aerosure device) and the control group (using an inactive sham device). The study was accordingly not adequate evidence of the efficacy



Because the trial was not placebo-controlled, we considered AcceleDent had not provided adequate evidence to support the claim AcceleDent, is also clinically proven to reduce the pain and discomfort associated with braces and aligners by up to 71%. We concluded that the claim had not been substantiated and was misleading.

On that point the claim breached CAP Code (Edition 12) rules 3.1 (Misleading advertising), 3.7 (Substantiation) and 12.1 Medicines, medical devices, health-related products and beauty products.



Assessment
Upheld

The ASA noted that the product appeared to meet the requirements of the Medical Device Directive (MDD) but understood that the MDD did not harmonise EU law relating the advertising of medical devices, which was subject to Directive 2005/29/EC on unfair business to consumer commercial practices (including advertising) generally (Unfair commercial practices directive - UCPD). That meant that advertisers must still meet the requirements of the CAP Code, which reflected the provisions of UCPD. Under the CAP and BCAP Codes, medical claims could be made for CE-marked medical devices provided they complied with other requirements of the Codes, including those relating to substantiation.
CE certification in itself does not constitute evidence for medical efficacy claims, and advertisers need to ensure that they hold evidence for such claims.
There was no statistically significant difference between the outcomes for the treatment group (patients using the Aerosure device) and the control group (using an inactive sham device). The study was accordingly not adequate evidence of the efficacy

lbo
Chat Pages: Latest  749  748  747  746  745  744  743  742  741  740  739  738  Older

Your Recent History

Delayed Upgrade Clock